Home » Topics » Regulatory

Regulatory
RSS

Pennsaid submitted to FDA for approval

Dec. 16, 1997

Migranal Nasal Spray approved by FDA

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...